Magda Kosmopoulou

1.3k total citations
26 papers, 925 citations indexed

About

Magda Kosmopoulou is a scholar working on Molecular Biology, Organic Chemistry and Rheumatology. According to data from OpenAlex, Magda Kosmopoulou has authored 26 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Organic Chemistry and 11 papers in Rheumatology. Recurrent topics in Magda Kosmopoulou's work include Carbohydrate Chemistry and Synthesis (12 papers), Glycogen Storage Diseases and Myoclonus (11 papers) and Biochemical and Molecular Research (9 papers). Magda Kosmopoulou is often cited by papers focused on Carbohydrate Chemistry and Synthesis (12 papers), Glycogen Storage Diseases and Myoclonus (11 papers) and Biochemical and Molecular Research (9 papers). Magda Kosmopoulou collaborates with scholars based in Greece, United Kingdom and Hungary. Magda Kosmopoulou's co-authors include Nikos G. Oikonomakos, D.D. Leonidas, Evangelia D. Chrysina, James Spencer, Philip Hinchliffe, María F. Mojica, Graciela Mahler, Leticia I. Llarrull, Robert A. Bonomo and Alejandro J. Vila and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemistry.

In The Last Decade

Magda Kosmopoulou

26 papers receiving 915 citations

Peers

Countries citing papers authored by Magda Kosmopoulou

Since Specialization

Citations

This map shows the geographic impact of Magda Kosmopoulou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda Kosmopoulou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda Kosmopoulou more than expected).

Fields of papers citing papers by Magda Kosmopoulou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magda Kosmopoulou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda Kosmopoulou. The network helps show where Magda Kosmopoulou may publish in the future.

Co-authorship network of co-authors of Magda Kosmopoulou

This figure shows the co-authorship network connecting the top 25 collaborators of Magda Kosmopoulou. A scholar is included among the top collaborators of Magda Kosmopoulou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magda Kosmopoulou. Magda Kosmopoulou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Crystal structures of VIM‐1 complexes explain active site heterogeneity in VIM‐class metallo‐β‐lactamases 2018 ·FEBS Journal ·(unknown), Philip Hinchliffe, Magda Kosmopoulou, Jonathan M. Tyrrell, Jürgen Brem, Sander S. van Berkel, Anil Kumar Verma, Raymond J. Owens, M.A. McDonough, Timothy R. Walsh, Christopher J. Schofield, James Spencer	32
2	Cyclobutanone Mimics of Intermediates in Metallo‐β‐Lactamase Catalysis 2017 ·Chemistry - A European Journal ·Martine I. Abboud, Magda Kosmopoulou, (unknown), Jarrod W. Johnson, Philip Hinchliffe, Jürgen Brem, Timothy D. W. Claridge, James Spencer, Christopher J. Schofield, Gary I. Dmitrienko	24
3	Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes 2016 ·Proceedings of the National Academy of Sciences ·Philip Hinchliffe, Mariano M. González, María F. Mojica, Javier González, (unknown), Cecilia Saiz, Magda Kosmopoulou, Catherine L. Tooke, Leticia I. Llarrull, Graciela Mahler, Robert A. Bonomo, Alejandro J. Vila, James Spencer	111
4	7-(Pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine-based derivatives for kinase inhibition: Co-crystallisation studies with Aurora-A reveal distinct differences in the orientation of the pyrazole N1-substituent 2015 ·Bioorganic & Medicinal Chemistry Letters ·Vassilios Bavetsias, Yolanda Pérez-Fuertes, Patrick J. McIntyre, Butrus Atrash, Magda Kosmopoulou, (unknown), Rosemary Burke, Chongbo Sun, Amir Faisal, (unknown), (unknown), Alan T. Henley, Florence I. Raynaud, Spiros Linardopoulos, Richard Bayliss, Julian Blagg	13
5	Crystal Structure of DIM-1, an Acquired Subclass B1 Metallo-β-Lactamase from Pseudomonas stutzeri 2015 ·PLoS ONE ·(unknown), Magda Kosmopoulou, Laurent Poirel, Patrice Nordmann, James Spencer	2
6	Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase 2015 ·ACS Infectious Diseases ·Mariano M. González, Magda Kosmopoulou, María F. Mojica, (unknown), Philip Hinchliffe, I. Pettinati, Jürgen Brem, Christopher J. Schofield, Graciela Mahler, Robert A. Bonomo, Leticia I. Llarrull, James Spencer, Alejandro J. Vila	95
7	Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases 2015 ·Biochemistry ·María F. Mojica, Graciela Mahler, Christopher R. Bethel, Magdalena A. Taracila, Magda Kosmopoulou, Krisztina M. Papp‐Wallace, Leticia I. Llarrull, Brigid Wilson, Steven H. Marshall, (unknown), María Virginia Villegas, Michael E. Harris, Alejandro J. Vila, James Spencer, Robert A. Bonomo	40
8	N-(4-Substituted-benzoyl)-N′-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods 2012 ·Bioorganic & Medicinal Chemistry ·Véronika Nagy, (unknown), (unknown), Jean‐Pierre Praly, Tibor Docsa, Pál Gergely, Evangelia D. Chrysina, C. Tiraidis, Magda Kosmopoulou, (unknown), (unknown), D.D. Leonidas, S.E. Zographos, Nikos G. Oikonomakos, Stanislav Kozmon, Igor Tvaroška, László Somsák	12
9	Structure-based design of imidazo[1,2-a]pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells 2010 ·Bioorganic & Medicinal Chemistry Letters ·Nathalie Bouloc, Jonathan M. Large, Magda Kosmopoulou, Chongbo Sun, Amir Faisal, Mizio Matteucci, Jóhannes Reynisson, Nathan J. Brown, Butrus Atrash, Julian Blagg, Edward McDonald, Spiros Linardopoulos, Richard Bayliss, Vassilios Bavetsias	27
10	Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site 2006 ·Bioorganic & Medicinal Chemistry ·(unknown), Catherine Arden, Loranne Agius, (unknown), Magda Kosmopoulou, C. Tiraidis, Yiannis Elemes, Constantinos Sakarellos, D.D. Leonidas, Nikos G. Oikonomakos	23
11	Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs 2005 ·Protein Science ·Nikos G. Oikonomakos, Magda Kosmopoulou, Evangelia D. Chrysina, D.D. Leonidas, Ioannis D. Kostas, K. Ulrich Wendt, Thomas Klabunde, Elisabeth Defoßa	21
12	Crystallographic studies on two bioisosteric analogues, N-acetyl-β-d-glucopyranosylamine and N-trifluoroacetyl-β-d-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase 2005 ·Bioorganic & Medicinal Chemistry ·Eleni Anagnostou, Magda Kosmopoulou, Evangelia D. Chrysina, D.D. Leonidas, (unknown), (unknown), S.E. Zographos, Zoltán Györgydeák, László Somsák, Tibor Docsa, Pál Gergely, Fragiskos N. Kolisis, Nikos G. Oikonomakos	19
13	Kinetic and crystallographic studies on 2‐(β‐D‐glucopyranosyl)‐5‐methyl‐1, 3, 4‐oxadiazole, ‐benzothiazole, and ‐benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site 2005 ·Protein Science ·Evangelia D. Chrysina, Magda Kosmopoulou, (unknown), (unknown), Nicolas Bischler, D.D. Leonidas, Zsuzsa Hadady, László Somsák, Tibor Docsa, Pál Gergely, Nikos G. Oikonomakos	76
14	Acyl Ureas as Human Liver Glycogen Phosphorylase Inhibitors for the Treatment of Type 2 Diabetes 2005 ·Journal of Medicinal Chemistry ·Thomas Klabunde, K. Ulrich Wendt, Dieter Kadereit, (unknown), Hans-Jörg Burger, Andreas W. Herling, Nikos G. Oikonomakos, Magda Kosmopoulou, Dieter Schmoll, Edoardo Sarubbi, (unknown), Karl Schönafinger, Elisabeth Defoßa	60
15	Binding of β-d-glucopyranosyl bismethoxyphosphoramidate to glycogen phosphorylase b: kinetic and crystallographic studies 2004 ·Bioorganic & Medicinal Chemistry ·Evangelia D. Chrysina, Magda Kosmopoulou, (unknown), Nicolas Bischler, D.D. Leonidas, (unknown), Duraikkannu Loganathan, Nikos G. Oikonomakos	14
16	Binding of the potential antitumour agent indirubin‐5‐sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b 2004 ·European Journal of Biochemistry ·Magda Kosmopoulou, D.D. Leonidas, Evangelia D. Chrysina, Nicolas Bischler, Gerhard Eisenbrand, Constantinos Sakarellos, Richard A. Pauptit, Nikos G. Oikonomakos	31
17	Crystallization and preliminary X-ray crystallographic analysis ofSclerotium rolfsiilectin 2003 ·Acta Crystallographica Section D Biological Crystallography ·D.D. Leonidas, Bale M. Swamy, (unknown), Shashikala R. Inamdar, Magda Kosmopoulou, Evangelia D. Chrysina, Nikos G. Oikonomakos	6
18	High‐resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure‐based design of ribonucleolytic inhibitors 2003 ·Protein Science ·D.D. Leonidas, G.B. Chavali, Nikos G. Oikonomakos, Evangelia D. Chrysina, Magda Kosmopoulou, Metaxia Vlassi, (unknown), K. Ravi Acharya	47
19	Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 Å resolution 2003 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Nikos G. Oikonomakos, Evangelia D. Chrysina, Magda Kosmopoulou, D.D. Leonidas	18
20	Binding of N‐acetyl‐N ′‐β‐d‐glucopyranosyl urea and N‐benzoyl‐N ′‐β‐d‐glucopyranosyl urea to glycogen phosphorylase b 2002 ·European Journal of Biochemistry ·Nikos G. Oikonomakos, Magda Kosmopoulou, S.E. Zographos, D.D. Leonidas, Evangelia D. Chrysina, László Somsák, Véronika Nagy, Jean‐Pierre Praly, Tibor Docsa, Béla Tóth, Pál Gergely	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact